Canakinumab in patients with COVID-19 and type 2 diabetes - A multicentre, randomised, double-blind, placebo-controlled trial.
EClinicalMedicine
; 53: 101649, 2022 Nov.
Article
in En
| MEDLINE
| ID: mdl-36128334
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Clinical_trials
Language:
En
Journal:
EClinicalMedicine
Year:
2022
Document type:
Article
Affiliation country:
Switzerland
Country of publication:
United kingdom